LPC
AMGN icon

Loeb Partners Corp’s Amgen AMGN Stock Holding History

Loeb Partners Corp’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,000
Closed -$1.17M – 141
2018
Q4 		$1.17M Hold
6,000
– – 0.54% 50
2018
Q3 		$1.24M Sell
6,000
-4,500
-43% -$887K 0.46% 51
2018
Q2 		$1.94M Buy
10,500
+6,500
+163% +$1.15M 0.49% 57
2018
Q1 		$682K Hold
4,000
– – 0.3% 74
2017
Q4 		$696K Buy
+4,000
New +$708K 0.21% 97
2017
Q2 		– Sell
-7,800
Closed -$1.28M – 166
2017
Q1 		$1.28M Hold
7,800
– – 0.39% 66
2016
Q4 		$1.14M Buy
7,800
+5,200
+200% +$783K 0.39% 65
2016
Q3 		$434K Buy
2,600
+600
+30% +$101K 0.15% 110
2016
Q2 		$304K Buy
+2,000
New +$311K 0.1% 125

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loeb Partners Corp's AMGN Position: Q1 2019 in Review

Loeb Partners Corp sold out of Amgen (AMGN) in Q1 2019, closing a stake of 6,000 shares — an estimated $1.17M sold.

Loeb Partners Corp first reported a position in AMGN in Q2 2016 and held it in 9 quarters. The position peaked at $1.94M in Q2 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Loeb Partners Corp reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 6,000 Amgen shares in Q1 2019, an estimated $1.17M.
  • Loeb Partners Corp first reported a position in Amgen in Q2 2016 and held it in 9 quarters.
  • Loeb Partners Corp's Amgen position peaked at $1.94M in Q2 2018.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.